Stoneridge Investment Partners’s Organogenesis Holdings ORGO Stock Holding History

Stoneridge Investment Partners’s Portfolio ORGO Stock Details ORGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-34,105	Closed	-$98K	–	157
2024 Q3	$98K	Hold	34,105	–	–	0.04%	102
2024 Q2	$95K	Hold	34,105	–	–	0.04%	116
2024 Q1	$97K	Buy	34,105 +20,802	+156%	+$70.7K	0.04%	109
2023 Q4	$54K	Hold	13,303	–	–	0.02%	90
2023 Q3	$42K	Hold	13,303	–	–	0.02%	97
2023 Q2	$44K	Sell	13,303 -8,620	-39%	-$25.5K	0.02%	105
2023 Q1	$47K	Buy	21,923 +11,592	+112%	+$28.6K	0.02%	94
2022 Q4	$28K	Hold	10,331	–	–	0.02%	94
2022 Q3	$33K	Buy	+10,331	New	+$46.7K	0.02%	93

Other funds holding ORGO

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Stoneridge Investment Partners's ORGO Position: Q4 2024 in Review

Stoneridge Investment Partners sold out of Organogenesis Holdings (ORGO) in Q4 2024, closing a stake of 34,105 shares — an estimated $98K sold.

Stoneridge Investment Partners first reported a position in ORGO in Q3 2022 and held it in 9 quarters. The position peaked at $98K in Q3 2024. 120 funds tracked by Wall St. Rank hold ORGO as of Q4 2024.

Stoneridge Investment Partners reported no remaining Organogenesis Holdings position as of Q4 2024 after selling out during the quarter.
Stoneridge Investment Partners sold 34,105 Organogenesis Holdings shares in Q4 2024, an estimated $98K.
Stoneridge Investment Partners first reported a position in Organogenesis Holdings in Q3 2022 and held it in 9 quarters.
Stoneridge Investment Partners's Organogenesis Holdings position peaked at $98K in Q3 2024.
120 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q4 2024.

Based on Stoneridge Investment Partners's 13F filing for Q4 2024, filed 28 Jan 2025.